Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1992 Nov;66(11):6626–6633. doi: 10.1128/jvi.66.11.6626-6633.1992

Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase.

R M Iorio 1, R L Glickman 1
PMCID: PMC240158  PMID: 1404607

Abstract

The Australia-Victoria (AV) isolate of Newcastle disease virus (NDV) induces fusion from within but not fusion from without. L1, a neuraminidase (NA)-deficient virus derived from AV, has the opposite fusion phenotype from the wild-type virus. It fails to induce the former mode of fusion, but has gained a limited ability to promote the latter. Monoclonal antibodies to antigenic site 23 on the hemagglutinin-neuraminidase (HN) glycoprotein have previously been shown to select variants of the AV isolate that have altered NA activity or receptor-binding affinity. By using an antibody to this site, variants of L1 have been selected. Three of the variants have gained an increased affinity for sialic acid-containing receptors, as evidenced by the resistance of their hemagglutinating activity to the presence of reduced amounts of sialic acid on the surface of chicken erythrocytes. All four variants still have very low levels of NA activity, comparable to that of the parent virus, L1. The alteration in receptor-binding affinity results in a decreased potential for elution from cellular receptors and correlates with an increased ability to promote both modes of fusion. A single amino acid substitution in the HN protein of each variant, responsible for its escape from neutralization, has been identified. These studies identify two HN residues, 193 and 203, at which monoclonal antibody-selected substitution influences the receptor recognition properties of NDV and may influence its ability to promote syncytium formation.

Full text

PDF
6626

Images in this article

6628Image
on p.6628
6628Image
on p.6628
6631Image
on p.6631

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alkhatib G., Richardson C., Shen S. H. Intracellular processing, glycosylation, and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirus. Virology. 1990 Mar;175(1):262–270. doi: 10.1016/0042-6822(90)90207-8. [DOI] [PubMed] [Google Scholar]
  2. Bratt M. A., Gallaher W. R. Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus. Proc Natl Acad Sci U S A. 1969 Oct;64(2):536–543. doi: 10.1073/pnas.64.2.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Choppin P. W., Scheid A. The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis. 1980 Jan-Feb;2(1):40–61. doi: 10.1093/clinids/2.1.40. [DOI] [PubMed] [Google Scholar]
  4. Chou P. Y., Fasman G. D. Prediction of protein conformation. Biochemistry. 1974 Jan 15;13(2):222–245. doi: 10.1021/bi00699a002. [DOI] [PubMed] [Google Scholar]
  5. Ebata S. N., Côté M. J., Kang C. Y., Dimock K. The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology. 1991 Jul;183(1):437–441. doi: 10.1016/0042-6822(91)90162-5. [DOI] [PubMed] [Google Scholar]
  6. Garnier J., Osguthorpe D. J., Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978 Mar 25;120(1):97–120. doi: 10.1016/0022-2836(78)90297-8. [DOI] [PubMed] [Google Scholar]
  7. Horvath C. M., Paterson R. G., Shaughnessy M. A., Wood R., Lamb R. A. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol. 1992 Jul;66(7):4564–4569. doi: 10.1128/jvi.66.7.4564-4569.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hu X. L., Ray R., Compans R. W. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol. 1992 Mar;66(3):1528–1534. doi: 10.1128/jvi.66.3.1528-1534.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Iorio R. M., Bratt M. A. Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites. J Immunol. 1984 Oct;133(4):2215–2219. [PubMed] [Google Scholar]
  10. Iorio R. M., Bratt M. A. Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin. Proc Natl Acad Sci U S A. 1985 Oct;82(20):7106–7110. doi: 10.1073/pnas.82.20.7106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iorio R. M., Glickman R. L., Riel A. M., Sheehan J. P., Bratt M. A. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. Virus Res. 1989 Jul;13(3):245–261. doi: 10.1016/0168-1702(89)90019-1. [DOI] [PubMed] [Google Scholar]
  12. Iorio R. M., Syddall R. J., Glickman R. L., Riel A. M., Sheehan J. P., Bratt M. A. Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virus. Virology. 1989 Nov;173(1):196–204. doi: 10.1016/0042-6822(89)90235-3. [DOI] [PubMed] [Google Scholar]
  13. Iorio R. M., Syddall R. J., Sheehan J. P., Bratt M. A., Glickman R. L., Riel A. M. Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition. J Virol. 1991 Sep;65(9):4999–5006. doi: 10.1128/jvi.65.9.4999-5006.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McGinnes L. W., Wilde A., Morrison T. G. Nucleotide sequence of the gene encoding the Newcastle disease virus hemagglutinin-neuraminidase protein and comparisons of paramyxovirus hemagglutinin-neuraminidase protein sequences. Virus Res. 1987 May;7(3):187–202. doi: 10.1016/0168-1702(87)90027-x. [DOI] [PubMed] [Google Scholar]
  15. Merz D. C., Wolinsky J. S. Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein. Virology. 1983 Dec;131(2):328–340. doi: 10.1016/0042-6822(83)90501-9. [DOI] [PubMed] [Google Scholar]
  16. Morrison T., McQuain C., McGinnes L. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol. 1991 Feb;65(2):813–822. doi: 10.1128/jvi.65.2.813-822.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moscona A., Peluso R. W. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. J Virol. 1991 Jun;65(6):2773–2777. doi: 10.1128/jvi.65.6.2773-2777.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Olmsted R. A., Elango N., Prince G. A., Murphy B. R., Johnson P. R., Moss B., Chanock R. M., Collins P. L. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7462–7466. doi: 10.1073/pnas.83.19.7462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Paterson R. G., Hiebert S. W., Lamb R. A. Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7520–7524. doi: 10.1073/pnas.82.22.7520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sakaguchi T., Toyoda T., Gotoh B., Inocencio N. M., Kuma K., Miyata T., Nagai Y. Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology. 1989 Apr;169(2):260–272. doi: 10.1016/0042-6822(89)90151-7. [DOI] [PubMed] [Google Scholar]
  21. Sakai Y., Shibuta H. Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes. J Virol. 1989 Sep;63(9):3661–3668. doi: 10.1128/jvi.63.9.3661-3668.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schaper U. M., Fuller F. J., Ward M. D., Mehrotra Y., Stone H. O., Stripp B. R., De Buysscher E. V. Nucleotide sequence of the envelope protein genes of a highly virulent, neurotropic strain of Newcastle disease virus. Virology. 1988 Jul;165(1):291–295. doi: 10.1016/0042-6822(88)90686-1. [DOI] [PubMed] [Google Scholar]
  23. Scheid A., Choppin P. W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology. 1974 Feb;57(2):475–490. doi: 10.1016/0042-6822(74)90187-1. [DOI] [PubMed] [Google Scholar]
  24. Sheehan J. P., Iorio R. M. A single amino acid substitution in the hemagglutinin-neuraminidase of Newcastle disease virus results in a protein deficient in both functions. Virology. 1992 Aug;189(2):778–781. doi: 10.1016/0042-6822(92)90605-o. [DOI] [PubMed] [Google Scholar]
  25. Sheehan J. P., Iorio R. M., Syddall R. J., Glickman R. L., Bratt M. A. Reducing agent-sensitive dimerization of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus correlates with the presence of cysteine at residue 123. Virology. 1987 Dec;161(2):603–606. doi: 10.1016/0042-6822(87)90158-9. [DOI] [PubMed] [Google Scholar]
  26. Shibuta H., Kanda T., Hazama A., Adachi A., Matumoto M. Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity. Infect Immun. 1981 Oct;34(1):262–267. doi: 10.1128/iai.34.1.262-267.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shibuta H., Nozawa A., Shioda T., Kanda T. Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virus. Infect Immun. 1983 Aug;41(2):780–788. doi: 10.1128/iai.41.2.780-788.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shioda T., Wakao S., Suzu S., Shibuta H. Differences in bovine parainfluenza 3 virus variants studied by sequencing of the genes of viral envelope proteins. Virology. 1988 Feb;162(2):388–396. doi: 10.1016/0042-6822(88)90479-5. [DOI] [PubMed] [Google Scholar]
  29. Smith G. W., Hightower L. E. Biological consequences of neuraminidase deficiency in Newcastle disease virus. J Virol. 1983 Sep;47(3):385–391. doi: 10.1128/jvi.47.3.385-391.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Smith G. W., Hightower L. E. Revertant analysis of a temperature-sensitive mutant of Newcastle disease virus with defective glycoproteins: implication of the fusion glycoprotein in cell killing and isolation of a neuraminidase-deficient hemagglutinating virus. J Virol. 1982 May;42(2):659–668. doi: 10.1128/jvi.42.2.659-668.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tanabayashi K., Takeuchi K., Okazaki K., Hishiyama M., Yamada A. Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for cell fusion. Virology. 1992 Apr;187(2):801–804. doi: 10.1016/0042-6822(92)90482-5. [DOI] [PubMed] [Google Scholar]
  32. Underwood P. A. Receptor binding characteristics of strains of the influenza Hong Kong subtype, using a periodate sensitivity test. Arch Virol. 1985;84(1-2):53–61. doi: 10.1007/BF01310553. [DOI] [PubMed] [Google Scholar]
  33. Underwood P. A., Skehel J. J., Wiley D. C. Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J Virol. 1987 Jan;61(1):206–208. doi: 10.1128/jvi.61.1.206-208.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Waxham M. N., Aronowski J. Identification of amino acids involved in the sialidase activity of the mumps virus hemagglutinin-neuraminadase protein. Virology. 1988 Nov;167(1):226–232. doi: 10.1016/0042-6822(88)90072-4. [DOI] [PubMed] [Google Scholar]
  35. Waxham M. N., Wolinsky J. S. A fusing mumps virus variant selected from a nonfusing parent with the neuraminidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology. 1986 Jun;151(2):286–295. doi: 10.1016/0042-6822(86)90050-4. [DOI] [PubMed] [Google Scholar]
  36. Yewdell J. W., Caton A. J., Gerhard W. Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J Virol. 1986 Feb;57(2):623–628. doi: 10.1128/jvi.57.2.623-628.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES